# US 12,215,384 B2 · Methods of characterising target polynucleotides > Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt - Number: US 12,215,384 B2 - Document ID: US12215384B2 - Status: Granted - Kind: B2 - Application number: 16/304,077 - Filed: 2017-05-25 - Published: 2019-07-04 - Granted: 2025-02-04 - Earliest claimed: 2016-05-25 - Assignees: Oxford Nanopore Technologies PLC - Applicants: Oxford Nanopore Technologies PLC - Inventors: Richard Alexander Gutierrez; Andrew John Heron; James White - Web page: https://patentgrep.com/patent/US12215384B2 ## CPC - C12Q 1/6869: Methods for sequencing - C12Q 2565/631: being a biochannel or pore - C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES ## Abstract The invention relates to a new method of characterising a target polynucleotide using a pore. The method involves controlling the formation of secondary structure by the target polynucleotide after the polynucleotide has moved through the pore. ## Claims ### Claim 1 A method of characterising a target polynucleotide, comprising: (a) providing a transmembrane pore in a membrane having a cis side and a trans side and carrying out steps (b)-(d) under one applied potential; (b) contacting, on the cis side of the membrane, the target polynucleotide with the transmembrane pore and a molecular brake which controls the movement of a strand of the target polynucleotide through the transmembrane pore; (c) taking one or more measurements as the molecular brake controls the movement of the strand through the transmembrane pore, wherein the one or more measurements are indicative of one or more characteristics of the target polynucleotide as the target polynucleotide moves through the transmembrane pore; and (d) decreasing formation of secondary structure by the target polynucleotide by using an endonuclease on the trans side of the membrane to cleave a portion of the strand of the target polynucleotide that has translocated to the trans side of the membrane as the molecular brake controls movement of the strand of the target polynucleotide through the transmembrane pore. ### Claim 2 (depends on 1) The method according to claim 1, wherein the endonuclease decreases formation of random secondary structure by the target polynucleotide on the trans side of the membrane, wherein the random secondary structure comprises (a) one or more helices, (b) one or more loops, (c) one or more pseudoknots, (d) one or more quadruplexes, or (e) a combination thereof. ### Claim 3 (depends on 1) The method according to claim 1, wherein the molecular brake is a polynucleotide binding protein. ### Claim 4 (depends on 1) The method according to claim 1, wherein the transmembrane pore is (i) a protein pore or (ii) a solid state pore. ### Claim 5 (depends on 1) The method according to claim 1, wherein the entire target polynucleotide moves through the transmembrane pore and is characterised. ### Claim 6 (depends on 1) The method according to claim 1, wherein characterising the target polynucleotide comprises estimating the sequence of the target polynucleotide or sequencing the target polynucleotide. ### Claim 7 (depends on 1) The method according to claim 1, wherein the molecular brake is a polymerase, helicase or exonuclease. ### Claim 8 (depends on 1) The method according to claim 1, wherein the transmembrane pore is a protein pore or based on Msp, α-hemolysin (α-HL), lysenin, CsgG, ClyA, Sp1 or FraC. ### Claim 9 (depends on 1) The method according to claim 1, wherein the target polynucleotide is single-stranded. ### Claim 10 (depends on 1) The method according to claim 1, wherein the molecular brake is a helicase. ### Claim 11 A method characterising a target polynucleotide, wherein the target polynucleotide is double stranded and the method comprises: (a) providing a construct comprising the target polynucleotide in which the two strands of the target polynucleotide are linked at one end of the target polynucleotide by a hairpin loop; (b) providing a transmembrane pore in a membrane having a cis side and a trans side and carrying out steps (c)-(e) under one applied potential; (c) contacting, on the cis side of the membrane, the construct with the transmembrane pore and a molecular brake which separates the two strands of the construct and controls the movement of the construct through the transmembrane pore one strand at a time; (d) taking one or more measurements as the molecular brake controls the movement of the strand through the transmembrane pore, wherein the one or more measurements are indicative of one or more characteristics of the target polynucleotide as the construct moves through the transmembrane pore; and (e) decreasing formation of secondary structure by the target polynucleotide by using an endonuclease on the trans side of the membrane to cleave a portion of each strand of the target polynucleotide that has translocated to the trans side of the membrane as the molecular brake controls movement of the construct through the transmembrane pore one strand at a time. ### Claim 12 (depends on 11) The method according to claim 11, wherein the endonuclease decreases rehybridization of the two strands of the target polynucleotide on the trans side of the membrane or prevent the two strands of the target polynucleotide from rehybridising on the trans side of the membrane. ### Claim 13 (depends on 11) The method according to claim 11, wherein the molecular brake is a polynucleotide binding protein. ### Claim 14 (depends on 11) The method according to claim 11, wherein the transmembrane pore is (i) a protein pore or (ii) a solid state pore. ### Claim 15 (depends on 11) The method according to claim 11, wherein the entire target polynucleotide moves through the transmembrane pore and is characterised. ### Claim 16 (depends on 11) The method according to claim 11, wherein characterising the target polynucleotide comprises estimating the sequence of the target polynucleotide or sequencing the target polynucleotide. ### Claim 17 (depends on 11) The method according to claim 11, wherein the molecular brake is a polymerase, helicase or exonuclease. ### Claim 18 (depends on 11) The method according to claim 11, wherein the transmembrane pore is a protein pore or based on Msp, α-hemolysin (α-HL), lysenin, CsgG, ClyA, Sp1 or FraC. ### Claim 19 (depends on 11) The method according to claim 11, wherein the molecular brake is a helicase.